| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/1045-1056(91)90042-I |
| P8608 | Fatcat ID | release_4zipau5ffze4xi5oiczw5td5fm |
| P698 | PubMed publication ID | 1954005 |
| P2093 | author name string | Forsey T | |
| Minor PD | |||
| Heath AB | |||
| P433 | issue | 3 | |
| P921 | main subject | measles | Q79793 |
| P304 | page(s) | 237-241 | |
| P577 | publication date | 1991-07-01 | |
| P1433 | published in | Biologicals | Q4915041 |
| P1476 | title | The 1st International Standard for anti-measles serum. | |
| P478 | volume | 19 |
| Q77329354 | A simplified and standardized neutralization enzyme immunoassay for the quantification of measles neutralizing antibody |
| Q41004744 | A simplified immunoassay based on measles virus recombinant hemagglutinin protein for testing the immune status of vaccinees |
| Q36504515 | A study of maternally derived measles antibody in infants born to naturally infected and vaccinated women |
| Q80098417 | Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination |
| Q51804590 | Animal models and antibody assays for evaluating candidate SARS vaccines: summary of a technical meeting 25-26 August 2005, London, UK. |
| Q44200658 | Boosting effect of a second dose of measles vaccine given to 12-year-old children |
| Q53344098 | Calibration and use of an in-house anti-measles IgG standard serum. |
| Q33908929 | Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins |
| Q57714344 | Comparison of a commercial enzyme immunoassay with plaque reduction neutralization for maternal and infant measles antibody measurement. |
| Q36520317 | Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody |
| Q45390406 | Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination |
| Q37495055 | Differential immune responses to primary measles-mumps-rubella vaccination in Israeli children |
| Q36539048 | Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques |
| Q52038147 | Estimated susceptibility to asymptomatic secondary immune response against measles in late convalescent and vaccinated persons. |
| Q58855397 | Evaluation of different measles IgG assays based on recombinant proteins using a panel of low-titre sera |
| Q57940218 | Immune modulation after measles vaccination of 6-9 months old Bangladeshi infants |
| Q43694801 | Immunogenicity of high-titre AIK-C or Edmonston-Zagreb vaccines in 3.5-month-old infants, and of medium- or high-titre Edmonston-Zagreb vaccine in 6-month-old infants, in Kinshasa, Zaire |
| Q33659393 | Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity |
| Q53395686 | International reference preparation for anti-measles serum |
| Q39604467 | Measles IgG seroprevalence prior to mass vaccination in Taiwan |
| Q39476826 | Measles antibody levels in a vaccinated population in Brazil. |
| Q24650526 | Measles immunity and response to revaccination among secondary school children in Cumbria |
| Q39578418 | Measles seroepidemiology and decay rate of vaccine-induced measles IgG titers in Taiwan, 1995-1997. |
| Q44561676 | Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination |
| Q33803714 | Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies. |
| Q45741106 | Resistance of recent measles virus wild-type isolates to antibody-mediated neutralization by vaccinees with antibody |
| Q46797251 | Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial |
| Q50901726 | Response to measles revaccination among Bolivian school-aged children. |
| Q45155393 | The Second International Standard for anti-poliovirus sera types 1, 2 and 3 |
| Q73389261 | The effect of measles–mumps–rubella (MMR) immunization on the immune responses of previously immunized primary school children |
Search more.